Related references
Note: Only part of the references are listed.Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro
Kuang-Yuh Chyu et al.
PLOS ONE (2014)
Comparative Tolerability and Harms of Individual Statins: A Study-Level Network Meta-Analysis of 246 955 Participants From 135 Randomized, Controlled Trials
Huseyin Naci et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)
Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons from the Recent Clinical Trials
Alexios S. Antonopoulos et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease
Jinghong Kou et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Increased Membrane Cholesterol in Lymphocytes Diverts T-Cells toward an Inflammatory Response
Jacqueline Surls et al.
PLOS ONE (2012)
Statins in the critically ill
Isabelle De Loecker et al.
ANNALS OF INTENSIVE CARE (2012)
Proprotein Convertase Substilisin/Kexin Type 9 Antagonism Reduces Low-Density Lipoprotein Cholesterol in Statin-Treated Hypercholesterolemic Nonhuman Primates
Hong Liang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
E. J. Mills et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Simvastatin enhances immune responses to Aβ vaccination and attenuates vaccination-induced behavioral alterations
Jinghong Kou et al.
BRAIN RESEARCH (2010)
Liver X receptor in cholesterol metabolism
Chunyan Zhao et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters
Bin Dong et al.
JOURNAL OF LIPID RESEARCH (2010)
Lipid Rafts As a Membrane-Organizing Principle
Daniel Lingwood et al.
SCIENCE (2010)
Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques A Comparison of a Nonstatin-Based Regimen in Patients Undergoing Carotid Endarterectomy
Massimo Puato et al.
STROKE (2010)
Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases
Sek C. Chow
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation
Patrick C. Raemer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates
Joyce C. Y. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Statins induce regulatory T cell recruitment via a CCL1 dependent pathway
Emilia Mira et al.
JOURNAL OF IMMUNOLOGY (2008)
Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
Janice Mayne et al.
LIPIDS IN HEALTH AND DISEASE (2008)
Molecular basis for LDL receptor recognition by PCSK9
Hyock Joo Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The safety of statins in clinical practice
Jane Armitage
LANCET (2007)
Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat a of low density lipoprotein receptor decreases receptor recycling and increases degradation
Da-Wei Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein - A meta-analysis
Scott Kinlay
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Short-term atorvastatin treatment enhances specific antibody production following tetanus toxoid vaccination in healthy volunteers
Pui Y. Lee et al.
VACCINE (2006)
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
J Greenwood et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Statin safety: A systematic review
M Law et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing Microdomains
HF Kuipers et al.
HUMAN IMMUNOLOGY (2005)
Proprotein convertase subtilisin kexin 9: the third locus implicated in autosomal dominant hypercholesterolemia
KN Maxwell et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease
DZ Hillyard et al.
ATHEROSCLEROSIS (2004)
Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia
G Dubuc et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Share Paper
